All In MedTech

FDA Clearance Tracker · P970040

ACHILLES EXPRESS ULTRASONOMETER

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 21, 2026Latest source record: Jun 26, 1998 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P970040
Device name
ACHILLES EXPRESS ULTRASONOMETER
Applicant location
Madison, WI
Received
Sep 2, 1997
Decided
Jun 26, 1998
Decision
Approved (reclassified)
Supplements
3 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 892.1180

Every decision under product code MUA

FDA's approval statement

As written in FDA's record.

The device is indicated as follows: The Achilles+ultrasonometer measures ultrasound variables of the os calcis to provide a clinical measure called Stiffness Index. The Stiffnes Index indicateds risk of osteoporotic fracture in postmenopausal women comparable to bone mineral density (BMD) as measured by X-ray absorptiometry at teh spine or hip. Stiffness Index results expressed as T-scores are used to assist the physicians in the diagnosis of osteoporosis in the same way as are T-scores or obtained by X-ray absorpiometry. either the Stiffness Index T-score or X-ray absorptiometry T-score can be utilized by a physician, in conjunction with other clinical risk factors, to provide a comprehensive skeletal assessment. The Stiffness Index has a precision error in older women comparable to that of x-ray absorptiometry, which makes it suitable for moniotirng bone changes.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MUA. The earliest in FDA's data is P970017, decided Mar 12, 1998.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Ge Lunar Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.